ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1400 National Cancer Institute Html en Pruritus (PDQ®)–Patient Version Expert-reviewed information summary about pruritus (itching of the skin) as a complication of cancer or its treatment. Approaches to the management and treatment of pruritus are discussed.
pruritus0.90328
cancer treatment0.548786
pruritus triggers0.621529
itchy area0.539512
PDQ cancer information0.801119
sensitive skin0.546664
clinical trials0.578
slightly warm water0.581894
skin irritation0.524209
cancer information summary0.687111
clinical trial0.527617
breast cancer prevention0.527738
allergic skin reactions0.565555
PDQ summaries0.536776
NCI’s PDQ0.543089
NCI PDQ cancer0.611108
abnormally dry skin0.57148
radiation therapy0.699633
mild skin cleansers0.572586
healthy skin0.527165
dry skin0.774485
severe pruritus0.605619
treatment0.566915
skin reactions0.571172
cancer prevention0.529379
skin0.938312
fabric softener0.603284
Cancer Information Service0.550768
PDQ Supportive0.525373
Skin care0.536556
treatment clinical trials0.52545
National Cancer Institute0.683212
PDQ documents0.525692
pruritus feels0.65464
Palliative Care Editorial0.58903
new treatment0.528187
Long-term dry skin0.58669
Cancer Care page0.536284
PDQ database0.530553
Care Editorial Board0.591687
skin stay0.527676
PDQ summary0.56881
skin biopsy0.53042
sedimentation rate0.58564
skin cells0.531813
skin lesions0.545694
cancer information summaries0.561413
comprehensive cancer information0.556845
CLICK HERE
1573 National Cancer Institute Html en Paranasal Sinus and Nasal Cavity Cancer Treatment (PDQ®)–Patient Version Expert-reviewed information summary about the treatment of paranasal sinus and nasal cavity cancer.
clinical trial0.388177
treatment0.382326
nasal cavity cancer0.775733
nasal cavity0.985485
radiation therapy0.64284
cancer0.858763
paranasal sinus0.474859
clinical trials0.346263
CLICK HERE
1600 National Cancer Institute Html en Nutrition in Cancer Care (PDQ®)–Patient Version Expert-reviewed information summary about the causes and management of nutritional problems that occur in patients with cancer.
cancer treatment0.815724
foods0.591336
body0.50774
PDQ cancer information0.539768
general health0.483553
mouth sores0.564301
nutrition problems0.511061
cancer information summary0.514016
Cancer Care section0.490312
enteral nutrition0.493173
cancer care0.499373
cancer patients0.772982
weight loss0.581589
dry mouth0.559356
NCI PDQ cancer0.489458
nutrition0.675709
effects0.559624
good nutrition0.476052
nutrition therapy0.671346
radiation therapy0.583611
Advanced Cancer section0.512145
nutrition support care0.489001
cancer treatments0.531014
parenteral nutrition support0.491942
cancer prevention0.486895
cancer cells0.480334
Cancer Information Service0.511605
palliative care0.476957
nutrients0.514961
certain foods0.495203
parenteral nutrition0.492581
National Cancer Institute0.539267
advanced cancer0.530168
white blood cell0.522179
fight infection0.479873
low white blood0.494372
breast cancer0.518198
cancer patients control0.508745
health0.485589
food0.567108
PDQ summary0.508916
Eat foods0.503278
following nutrition problems0.482655
mouth0.591038
cancer information summaries0.483904
comprehensive cancer information0.47883
cancer0.980934
information0.558957
Cancer survivors0.484253
CLICK HERE
1729 National Cancer Institute Html en Hyperthermia in Cancer Treatment A fact sheet that defines hyperthermia (treating tumors with heat) and its side effects.
cancer treatment0.403898
peritoneal cavity temperature0.426528
External applicators0.382217
whole-body hyperthermia0.729094
van der Zee0.371709
Clinical Radiation Oncology.0.380706
tumor location0.365525
regional hyperthermia0.5725
hyperthermic peritoneal perfusion0.490656
metastatic cancer0.36336
Gibbs FA Jr0.369277
normal tissues0.422996
cancer therapy0.407309
hyperthermia treatment0.61506
bladder cancer0.363102
Deep tissue approaches0.386891
clinical trials0.532546
DeVita VT Jr.0.371357
interstitial hyperthermia0.571391
hyperthermia0.901227
tissue characteristics0.386571
hot water blankets0.375371
peritoneal cavity0.431179
hyperthermia techniques0.560349
radiation therapy0.457463
high temperatures0.42664
primary peritoneal mesothelioma0.407141
local hyperthermia0.597761
body cavity0.386007
cancer cells0.536875
anticancer drugs0.424955
Cancer Information Service0.393124
Libutti SK0.372166
tumor size0.36657
certain anticancer drugs0.383187
B.C. Decker Inc.0.373174
Samulski TV. Hyperthermia0.573888
Numerous clinical trials0.395138
Clinical Trials Information0.383207
malignant peritoneal mesothelioma0.399886
body tissue0.392759
Regional perfusion techniques0.40208
Bast RC Jr.0.371129
stomach cancer0.363295
tumor0.394758
inserts small needles0.373242
et al0.437187
higher temperatures0.384967
research studies0.385011
CLICK HERE
1739 National Cancer Institute Html en Paget Disease of the Breast A fact sheet about Paget disease of the breast, a rare type of cancer that is sometimes called Paget disease of the nipple or mammary Paget disease.
widely accepted theory0.431005
Paget disease0.968679
lymph node dissection0.448538
breast travel0.50595
Female Breast0.492116
benign skin conditions0.467839
invasive cancer0.46682
Breast Cancer Research0.515399
nearby lymph nodes0.47834
5-year relative survival0.483297
circular cutting tool0.430646
lymph node biopsy0.495901
sentinel lymph node0.515084
areola0.440286
entire nipple0.437315
additional diagnostic tests0.431017
Paget cells0.564932
breast tumor0.509157
lymph nodes0.480504
nipple biopsy0.469807
lymph node surgery0.448775
invasive breast cancer0.541802
breast lump0.501651
extramammary Paget disease0.567848
magnetic resonance imaging0.430693
cancer cells0.444445
breast cancer recurrence0.516664
benign skin condition0.434676
National Cancer Institute0.437477
tumor cells0.436713
early symptoms0.436544
rare type0.434028
breast changes0.501251
breast tumors0.519719
British doctor Sir0.43376
Breast Journal0.497022
clinical breast exam0.531889
breast cancer0.589051
HER2 protein overexpression0.430335
Sir James Paget0.592188
people0.452202
breast cancer treatments0.51665
lymph node involvement0.446932
darker circle0.435564
axillary lymph node0.477668
mammary Paget disease0.579396
et al0.471939
breast0.816594
Surgical Oncology0.430364
CLICK HERE
1920 National Cancer Institute Html es Tratamiento del cáncer de vejiga (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento del cáncer de vejiga.
pequeño bucle0.447801
siguientes procedimientos0.673413
Schistosoma haematobium0.482783
cistectomía segmentaria0.460288
estadio iv0.822603
cáncer.ampliar cistoscopia0.483661
pequeña cantidad0.462732
estadio ii0.569624
túbulos renales0.485429
siguientes tipos0.465952
rayos x0.462117
sistema urinario masculino0.534793
enlace drugs approved0.625136
células t0.506117
posibles signos0.638701
National Cancer Institute0.427365
pelvis renal0.667965
Instituto Nacional0.454933
PDQ Tratamiento0.458142
antecedentes familiares0.468632
Physician Data Query0.515351
Bladder Cancer0.523198
estadio iii0.506874
siguientes situaciones0.472048
vejiga almacena0.929353
pequeños hongos0.45501
panel derecho0.577787
células renales0.591906
siguientes sumarios0.537471
siguientes pruebas0.493409
siguientes estadios0.478175
CLICK HERE
1945 National Cancer Institute Html es Efectos tardíos del tratamiento anticanceroso en la niñez (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca de los problemas de salud que aparecen una vez que termina el tratamiento del cáncer.
cancer statistics0.312893
among adult survivors0.309342
health insurance0.30576
childhood leukemia survivors0.314627
Marrow Transplant Survivor0.306695
largo plazo0.353459
Cancer Survivor cohort0.310798
CA Cancer0.308516
group long-term follow-up0.307764
mortality among 5-year0.309974
health conditions0.3067
young adult cancers0.387348
late mortality0.309117
Ness KK0.312945
among childhood cancer0.329959
adult survivors0.341543
Hudson MM0.322937
among survivors0.313213
British Childhood Cancer0.315849
utilization among long-term0.306183
childhood cancer0.973475
cancer survivor study0.608871
late effects0.312383
SEER Cancer Statistics0.308306
long-term survivors0.338777
health care utilization0.307102
Survivor Study cohort0.310239
chronic health conditions0.305835
among adolescent survivors0.308292
Care Cancer0.309376
among 5-year survivors0.328567
Pediatr Blood Cancer0.42011
oncology group long-term0.310223
adolescent cancers0.313982
efectos tardíos0.375703
survivors research program0.306998
report from0.396085
National Cancer Institute0.308232
Oeffinger KC0.306859
health care0.314251
mortality among survivors0.308816
Clin Oncol0.375569
childhood cancer survivor0.872407
medical care0.307228
among long-term survivors0.315379
late mortality among0.306982
long-term follow-up guidelines0.320022
Outcomes Among Childhood0.309917
children's oncology group0.433388
CLICK HERE
3769 National Cancer Institute Html es Medicina de precisión en el tratamiento del cáncer Información sobre el papel que tiene la medicina de precisión en el tratamiento del cáncer.
precisión para tratamiento0.796037
máquina llamada secuenciador0.682468
cuáles cambios0.881741
cuáles tratamientos funcionarán0.880419
que los pacientes0.633734
campo de investigación0.604701
seguro médico0.550546
cáncer el cambio0.9829
responda el tumor0.621072
a cuáles tratamientos0.724195
CLICK HERE
3876 National Cancer Institute Html en The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) Apply for the NCI F99/K00 Award that helps late-stage doctoral candidates finish their training and then transition into cancer-focused research positions.
K00 phase institution0.388613
applicant institution0.265884
Research Doctoral candidates0.275389
Funding Opportunity Announcement0.903132
research supplies0.244496
Career Development Award0.350987
k00 award0.331719
Ph.D. dissertation requirements0.237088
phase institutional representative0.335728
project award period0.253621
indirect costs0.425626
NCI F99/K00 Predoc0.307817
Institutional Allowance0.281782
Career Development Support0.249362
Research Career Development0.347168
k00 phase0.762118
Research Plan section0.261319
career development skills0.241364
health-related Ph.D. program0.243519
F99 primary sponsor0.23706
Research Service Award0.312163
Individual Research Career0.265006
mandatory NCI-sponsored conference0.307767
Opportunity Announcement instructions0.260896
career development research0.317687
dissertation research project0.396866
Ph.D. degree program0.256222
valid U.S. visas0.237157
Postdoctoral Fellow Transition0.248842
Application Guide0.311615
NCI Predoctoral0.237727
F99 phase0.471921
dissertation research training0.299174
program staff0.238571
Program Staff Contact0.236142
Research Strategy0.247855
F99/K00 Award0.359733
F99 grant mechanism0.235643
assigned NCI Program0.270275
Development Award Supplemental0.254853
F99 award0.269956
fringe benefits0.272186
valid U.S. visa0.254123
career development0.562023
Research Plan Sections0.252481
Fellowship Applicant Section0.257658
F99/K00 Award application0.300758
health-related research field0.279872
Postdoctoral Research Direction0.273719
CLICK HERE
15846 National Cancer Institute Html en RAS Biochemistry and Biophysics This RAS Biochemistry and Biophysics lab investigates signaling by RAS proteins, which is regulated by the interactions with substrates, protein partners, and membranes.
cell membranes0.473685
Nuclear Magnetic Resonance0.585708
Biophysics Group team0.636374
mutant RAS0.650163
KRAS proteins0.677168
nanodiscs0.374828
cancer deaths0.469996
fully modified KRAS0.804703
different cancers0.503399
Washington University0.469252
analytical ultracentrifugation0.487353
protein-nanodisc complexes0.475228
atomic levels0.48075
stephena@mail.nih.gov0.45777
Ridge National Laboratory0.591017
Rodolfo Ghirlando0.472711
artificial lipid bilayers0.682865
KRAS4b protein0.638588
sensitive techniques0.481762
Carla Mattos0.458864
California0.350663
Northeastern University0.475122
RAS proteins0.703869
neutron scattering0.468073
RAS Biochemistry0.737959
different KRAS0.64483
different lipid compositions0.713219
Chris Stanley0.450409
fully modified KRAS4b0.914598
Jay Groves0.463932
interactions0.440981
intrinsic hydrolysis rates0.625326
numerous interacting partner0.64654
inner plasma membrane0.635847
Marco Tonelli0.478206
surrogate0.33572
St. Louis0.448878
Digestive Kidney Dieases0.603479
National Institute0.589812
Paul Henderson0.462542
single molecule analysis0.605131
different mutant proteins0.699255
dozen different mutants0.686498
biophysical assays0.484191
binding affinities0.477155
Steve Sligar0.461855
biophysics group0.812528
major oncogenic mutants0.687098
KRAS account0.631848
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.